Cordis has a new CEO
Former Spectranetics CEO Scott Drake has moved into the corner office at the cardiology and endovascular devices company Cordis.
Stay updated with breaking news from Hunter Philbrick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Former Spectranetics CEO Scott Drake has moved into the corner office at the cardiology and endovascular devices company Cordis.
Brokerage giant partners up with PE firm
Brokerage giant partners with private equity firm
Pharmaceutical distributor Cardinal Health plans to sell its medical device business to private-equity firm Hellman & Friedman.
Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman Investment company hopes to create technology accelerator to speed bringing new innovations to market March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to Hellman & Friedman (H&F) for approximately $1 billion. Hellman & Friedman is a global private equity firm with investments in high-quality growth businesses. It is partnering in the transaction with Ajax Health and Zeus Health to build the Cordis business. Ajax identifies and supports scaling up di...